PDG3- AN ECONOMIC EVALUATION OF COMBINATION THERAPY WITH PIOGLITAZONE (ACTOS, TAKEDA) IN TYPE 2 DIABETES MELLITUS FROM A SPANISH HEALTH-CARE PERSPECTIVE
Abstract
Authors
N Maniadakis J Sacristan J Reviriego W Hart R Jansen A Kielhorn A Brandt